Raymond James & Associates Mimedx Group, Inc. Call Options Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 08, 2022	SELL	$5.7 - $8.48 $22,800 - $33,920	-4,000 Reduced 10.0%	36,000 $7,000
Q3 2021 Nov 02, 2021	BUY	$5.52 - $15.83 $110,399 - $316,600	20,000 Added 100.0%	40,000 $21,000
Q1 2021 May 14, 2021	SELL	$8.48 - $11.28 $420,608 - $559,488	-49,600 Reduced 71.26%	20,000 $8,000
Q3 2017 Nov 13, 2017	BUY	$11.86 - $17.34 $41,510 - $60,690	3,500 Added 5.3%	69,600 $17,000
Q2 2017 Aug 14, 2017	BUY	N/A	66,100	66,100 $73,000

218

94.7M

221K

77.4K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $774M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.